JPWO2023187097A5 - - Google Patents
Info
- Publication number
- JPWO2023187097A5 JPWO2023187097A5 JP2024557929A JP2024557929A JPWO2023187097A5 JP WO2023187097 A5 JPWO2023187097 A5 JP WO2023187097A5 JP 2024557929 A JP2024557929 A JP 2024557929A JP 2024557929 A JP2024557929 A JP 2024557929A JP WO2023187097 A5 JPWO2023187097 A5 JP WO2023187097A5
- Authority
- JP
- Japan
- Prior art keywords
- alcohol
- composition
- composition according
- bacillus
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2204716.1 | 2022-03-31 | ||
| GB2204716.1A GB2617183B (en) | 2022-03-31 | 2022-03-31 | Alcohol degrading compositions and uses thereof |
| PCT/EP2023/058370 WO2023187097A1 (en) | 2022-03-31 | 2023-03-30 | Alcohol degrading compositions and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025511131A JP2025511131A (ja) | 2025-04-15 |
| JPWO2023187097A5 true JPWO2023187097A5 (https=) | 2026-03-27 |
| JP2025511131A5 JP2025511131A5 (https=) | 2026-03-27 |
Family
ID=81581547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557929A Pending JP2025511131A (ja) | 2022-03-31 | 2023-03-30 | アルコール分解組成物及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250213626A1 (https=) |
| EP (1) | EP4499048A1 (https=) |
| JP (1) | JP2025511131A (https=) |
| KR (1) | KR20240167863A (https=) |
| CN (1) | CN119343134A (https=) |
| AU (1) | AU2023246874A1 (https=) |
| CA (1) | CA3246845A1 (https=) |
| GB (1) | GB2617183B (https=) |
| WO (1) | WO2023187097A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2621976B (en) * | 2022-08-19 | 2024-11-20 | De Faire Medical Ab | Compositions for use in treating and/or preventing type 2 diabetes, pre-diabetes, and/or a symptom thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH069474B2 (ja) * | 1990-03-20 | 1994-02-09 | 有限会社ビセイケン | アルコール耐性付与醗酵物の製造方法及びアルコール耐性付与醗酵食品 |
| JP4854841B2 (ja) * | 2000-09-18 | 2012-01-18 | 株式会社東洋発酵 | 肝障害低減剤 |
| KR100661032B1 (ko) * | 2005-04-19 | 2006-12-22 | 주식회사한국야쿠르트 | 간 기능 개선, 혈중 알코올 감소 및 항산화에 유효한조성물 |
| CN101731630B (zh) * | 2010-01-22 | 2012-10-10 | 完美（中国）有限公司 | 一种具有解酒、护肝功效的保健食品 |
| FI127823B (en) * | 2015-03-06 | 2019-03-15 | Biohit Oyj | Composition for preventing hangover symptoms |
| KR101853603B1 (ko) * | 2017-05-18 | 2018-05-02 | 주식회사 쎌바이오텍 | 알코올 또는 아세트알데하이드 분해용 프로바이오틱스를 포함하는 조성물 |
| KR20190091053A (ko) * | 2018-01-26 | 2019-08-05 | 주식회사 케이엠에프 | 아미노산 강화분말을 유효성분으로 포함하는 숙취개선용 조성물 및 그 제조방법 |
-
2022
- 2022-03-31 GB GB2204716.1A patent/GB2617183B/en active Active
-
2023
- 2023-03-30 CA CA3246845A patent/CA3246845A1/en active Pending
- 2023-03-30 WO PCT/EP2023/058370 patent/WO2023187097A1/en not_active Ceased
- 2023-03-30 AU AU2023246874A patent/AU2023246874A1/en active Pending
- 2023-03-30 US US18/851,739 patent/US20250213626A1/en active Pending
- 2023-03-30 EP EP23717428.9A patent/EP4499048A1/en active Pending
- 2023-03-30 CN CN202380039669.9A patent/CN119343134A/zh active Pending
- 2023-03-30 KR KR1020247035468A patent/KR20240167863A/ko active Pending
- 2023-03-30 JP JP2024557929A patent/JP2025511131A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mukhopadhya et al. | Gut microbiota-derived short-chain fatty acids and their role in human health and disease | |
| JP6908332B2 (ja) | 病原性細菌生育の抑制のための組成物および方法 | |
| US11793841B2 (en) | Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome | |
| Li et al. | Saccharomyces boulardii alleviates DSS-induced intestinal barrier dysfunction and inflammation in humanized mice | |
| EP2040724B1 (en) | Biotherapeutic compositions comprising probiotic escherichia coli and metronidazole and uses thereof | |
| Haseyama et al. | Pulmonary vasodilation therapy with sildenafil citrate in a patient with plastic bronchitis after the Fontan procedure for hypoplastic left heart syndrome | |
| JP2019520340A5 (https=) | ||
| BR112020018360A2 (pt) | Composições para uso no equilíbrio do microbioma | |
| CN114470010B (zh) | 乳双歧杆菌bl-11的新用途 | |
| JP2019516775A (ja) | プロバイオティクス及び消化酵素の組成物並びにその調製方法及び使用 | |
| RU2005134223A (ru) | Композиции, содержащие штаммы lactobacillus plantarum в сочетании с танином и новые штаммы lactobacillus plantarum | |
| EA021890B1 (ru) | Способ предотвращения и/или лечения болезни воспаленного кишечника, язвенного колита и болезни крона | |
| McKenney et al. | Microbiota and pathogen ‘pas de deux’: setting up and breaking down barriers to intestinal infection | |
| Navarro-López et al. | Oral intake of Kluyveromyces marxianus B0399 plus Lactobacillus rhamnosus CECT 30579 to mitigate symptoms in COVID-19 patients: A randomized open label clinical trial | |
| KR20230024867A (ko) | 다발성 염증성 장애의 치료 또는 예방을 위한 제약 조성물 | |
| KR20250052330A (ko) | 장 상피 손상 질환 치료를 위한 멜라토닌과 pge2의 병용 투여용 약학 조성물 | |
| JPWO2023187097A5 (https=) | ||
| CN119464165B (zh) | 口腔链球菌zrsor-5及其相关产品、方法及应用 | |
| US20230414599A1 (en) | Nicotinamide, nicotinamide precursors and nicotinamide metabolites and compositions thereof for reducing the time to resolution of symptoms in patients with covid-19 and other viral infections | |
| Al-Judaibi | Microbiota and their Influence in the Human Body. | |
| JP5358219B2 (ja) | 腸疾患治療剤 | |
| US20070059292A1 (en) | Use of enterococcus faecium strains for curing hepatic insufficiency and for regenerating and intensifying metabolism in a liver | |
| EA034885B1 (ru) | Новая схема лечения тиакумициновым соединением | |
| Mahajan et al. | The significance of water-soluble vitamins in SARS and related infections | |
| CN116635025A (zh) | 用于缩短covid-19和其他病毒感染患者的症状消退时间的烟酰胺、烟酰胺前体和烟酰胺代谢物及其组合物 |